Is this a piece of news regarding world politics, sports, business, or science and technology?
Genzyme to buy back rights Genzyme Corp. of Cambridge, Mass., agreed Thursday to buy back the sales and marketing rights for Synvisc, a pain treatment for people suffering from osteoarthritis of the knee, from Wyeth Pharmaceuticals of Collegeville, Pa. 
